Answer
No pharmacokinetic interactions are expected between lebrikizumab and other medicines because it is a monoclonal antibody, although no interaction studies have been performed.
Sources for this answer
- Ebglyss 250 mg solution for injection in pre-filled syringeAlmirall Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 5Document updated
Sources checked